Oncopharmpod
Keynote 811 Update
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:12:59
- More information
Informações:
Synopsis
The updated Keynote 811 OS results convert an accelerated approval for pembrolizumab to a regular approval, albeit restricted by PD-L1 CPS status of 1 or higher.
